ModelEdge

Albireo Pharma, Inc.
0001322505
Filing TypeSC TO-T
Filing Date1/22/2023
Updated1/23/23, 1:11 AM

Filing

SC TO-T
Earnings Release

Exhibits

SC TO-TTender Offer Statement by Third Party
EX-99.(A)(1)(A)OFFER TO PURCHASE
EX-99.(A)(1)(B)LETTER OF TRANSMITTAL
EX-99.(A)(1)(C)NOTICE OF GUARANTEED DELIVERY
EX-99.(A)(1)(D)LETTER TO BROKERS,DEALERS,COMMERCIAL BANKS, TRUST COMPANIES AND OTHER NOMINEES
EX-99.(A)(1)(E)LETTER TO CLIENTS FOR USE BY BROKERS, DEALERS, ETC
EX-99.(A)(1)(F)FORM OF SUMMARY ADVERTISEMENT
EX-99.(B)(1)REVOLVING FACILITY AGREEMENT
EX-99.(D)(2)(A)MUTUAL CONFIDENTIALITY AGREEMENT, BY AND BETWEEN ALBIREO AND IPSEN BIOSCIENCE IN
EX-99.(D)(2)(B)MUTUAL CONFIDENTIALITY AGREEMENT, BY AND BETWEEN ALBIREO AND GUARANTOR
EX-99.(D)(3)EX-99.(D)(3)
EX-FILING FEESEX-FILING FEES
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic